Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Novan Inc
(NQ:
NOVN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Novan Inc
Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection
July 17, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
June 05, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan Focuses Strategic Direction and Announces Restructuring
May 31, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 15, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan to Report First Quarter 2023 Financial Results on May 15, 2023
May 08, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement¹
April 27, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD
April 20, 2023
Live moderated webcast with members of the Novan management team and dermatological key opinion leader, Dr. Jeffrey Sugarman on Tuesday, April 25th at 2:00 PM ET
From
Novan, Inc.
Via
GlobeNewswire
Novan Reports Full Year 2022 Financial Results and Provides Corporate Update
March 30, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan to Report Full Year 2022 Financial Results on March 30, 2023
March 23, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan Announces Closing of $6.0 Million Registered Direct Offering
March 16, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 14, 2023
Presentation with live webcast today, March 14th at 10:40 AM ET
From
Novan, Inc.
Via
GlobeNewswire
Novan Announces $6.0 Million Registered Direct Offering
March 14, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan Moves Forward with Unified Corporate Branding
March 08, 2023
From
Novan, Inc.
Via
GlobeNewswire
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024
March 07, 2023
From
Novan, Inc.
Via
GlobeNewswire
Novan to Present at the Virtual Investor 2023 Companies to Watch Event
January 18, 2023
Live video webcast on Thursday, January 19th at 12:00 PM ET
From
Novan, Inc.
Via
GlobeNewswire
JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th
January 11, 2023
Via
ACCESSWIRE
Novan Submits New Drug Application to the U.S. FDA for Berdazimer Gel, 10.3% (SB206) for the Treatment of Molluscum Contagiosum
January 06, 2023
From
Novan, Inc.
Via
GlobeNewswire
EPI Health, a Novan Company, Enters into Exclusive License Agreement with Sato Pharmaceutical Co., Ltd. for RHOFADE® in Japan
December 21, 2022
From
Novan, Inc.
Via
GlobeNewswire
EPI Health, a Novan Company, Executes a $15.0 Million Financing Agreement
December 02, 2022
From
Novan, Inc.
Via
GlobeNewswire
Novan to Participate in the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & Medtech Conference
December 01, 2022
From
Novan, Inc.
Via
GlobeNewswire
Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 14, 2022
From
Novan, Inc.
Via
GlobeNewswire
Novan to Report Third Quarter 2022 Financial Results on November 14, 2022
November 07, 2022
From
Novan, Inc.
Via
GlobeNewswire
EPI Health, a Novan Company, and MC2 Therapeutics Present New Data In Multiple Posters Highlighting WYNZORA’s® Unique PAD Technology™ at the 42nd Annual Fall Clinical Dermatology Conference®
October 21, 2022
Research shows PAD (Polyaphron Dispersion) Technology™ leads to more efficient delivery of Calcipotriene (CAL) and Betamethasone Dipropionate (BDP) than CAL/BDP topical suspension
From
Novan, Inc.
Via
GlobeNewswire
EPI Health, a Novan Company, and MC2 Therapeutics Announce Data from Survey Conducted by National Psoriasis Foundation Presented at 42nd Annual Fall Clinical Dermatology Conference®
October 21, 2022
Data collected shows importance of treatment formulation characteristics and speed of improvement in psoriasis symptoms to patient treatment adherence
From
Novan, Inc.
Via
GlobeNewswire
Novan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference®
October 14, 2022
From
Novan, Inc.
Via
GlobeNewswire
JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th
November 04, 2021
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast roundtable discussions with members of Management and Thought Leaders across participating...
From
JTC Team, LLC
Via
AccessWire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.